Publication | Open Access
Comparison of Management and Outcomes in <i>ERBB2</i>-Low vs <i>ERBB2</i>-Zero Metastatic Breast Cancer in France
34
Citations
25
References
2022
Year
In this large cohort study, patients with ERBB2-low MBC had a slightly better OS than those with completely ERBB2-zero tumors, but identical PFS1, which could help guide treatment selection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1